U.S. flag

An official website of the United States government

PMC Full-Text Search Results

Items: 3

1.
Figure 1

Figure 1. From: Reduced Risk of Colorectal Cancer With Metformin Therapy in Patients With Type 2 Diabetes.

Flowchart of study selection process.

Zhi-Jiang Zhang, et al. Diabetes Care. 2011 Oct;34(10):2323-2328.
2.
Figure 3

Figure 3. From: Reduced Risk of Colorectal Cancer With Metformin Therapy in Patients With Type 2 Diabetes.

Pooled estimate of relative risk and 95% CIs of colorectal cancer associated with metformin therapy based on four studies comprising 107,961 diabetic patients and 589 incident colorectal cancer cases. Squares indicate relative risk in each study. The square size is proportional to the weight of the corresponding study in the meta-analysis; the length of horizontal lines represents the 95% CI. The unshaded diamond indicates the pooled relative risk and 95% CI.

Zhi-Jiang Zhang, et al. Diabetes Care. 2011 Oct;34(10):2323-2328.
3.
Figure 2

Figure 2. From: Reduced Risk of Colorectal Cancer With Metformin Therapy in Patients With Type 2 Diabetes.

Pooled estimate of relative risk and 95% CIs of colorectal neoplasm associated with metformin therapy based on five studies comprising 108,161 patients with type 2 diabetes. Squares indicate relative risk in each study. The square size is proportional to the weight of the corresponding study in the meta-analysis; the length of horizontal lines represents the 95% CI. The unshaded diamond indicates the pooled relative risk and 95% CI.

Zhi-Jiang Zhang, et al. Diabetes Care. 2011 Oct;34(10):2323-2328.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center